Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Prague - Delayed Quote CZK

Pilulka Lékárny a.s. (PINK.PR)

Compare
189.00
+4.00
+(2.16%)
At close: April 17 at 3:36:44 PM GMT+2
Currency in CZK All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,131,849
2,131,849
2,447,297
2,380,297
1,780,216
Cost of Revenue
1,962,728
1,962,728
2,187,702
2,142,702
1,582,033
Gross Profit
169,121
169,121
259,595
237,595
198,183
Operating Expense
317,676
317,676
307,270
251,581
197,126
Operating Income
-148,555
-148,555
-47,675
-13,986
1,057
Net Non Operating Interest Income Expense
-27,316
-27,316
-16,337
-10,690
-26,150
Pretax Income
-175,871
-175,871
-64,011
-24,676
-25,093
Tax Provision
4
4
1,747
994
549
Net Income Common Stockholders
-174,943
-174,943
-64,938
-25,495
-21,857
Diluted NI Available to Com Stockholders
-174,943
-174,943
-64,938
-25,495
-21,857
Basic EPS
-68.67
--
-25.49
-10.09
-8.65
Diluted EPS
-68.67
--
-25.49
-10.09
-8.65
Basic Average Shares
2,547.54
--
2,547.54
2,526.32
2,526.32
Diluted Average Shares
2,547.54
--
2,547.54
2,526.32
2,526.32
Total Operating Income as Reported
-148,555
-148,555
-47,674
-13,986
1,057
Total Expenses
2,280,404
2,280,404
2,494,972
2,394,283
1,779,159
Net Income from Continuing & Discontinued Operation
-174,943
-174,943
-64,938
-25,495
-21,857
Normalized Income
-174,943
-174,943
-64,938
-25,495
-21,857
Interest Income
49
49
206
714
28
Interest Expense
10,481
10,481
4,764
777
2,531
Net Interest Income
-27,316
-27,316
-16,337
-10,690
-26,150
EBIT
-165,390
-165,390
-59,247
-23,899
-22,562
EBITDA
-91,303
-91,303
-8,425
-1,114
-3,460
Reconciled Cost of Revenue
1,962,728
1,962,728
2,187,702
2,142,702
1,582,033
Reconciled Depreciation
74,087
74,087
50,822
22,785
19,102
Net Income from Continuing Operation Net Minority Interest
-174,943
-174,943
-64,938
-25,495
-21,857
Total Unusual Items Excluding Goodwill
--
--
--
--
-13,881
Total Unusual Items
--
--
--
--
-13,881
Normalized EBITDA
-91,303
-91,303
-8,425
-1,114
-3,460
Tax Rate for Calcs
0
0
0
0
0
12/31/2020 - 10/26/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade